This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,721.18 firm fixed-price delivery order is for the supply of 4,566,612,620 units of the pharmaceutical product Ondansetron HCl 4 mg tablets. The contract has an ultimate completion date of December 5, 2024 and was awarded on December 4, 2024. This award is associated with AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Generated 3/9/25, 1:01 AM